Novacea said Bradford Goodwin has resigned as CEO and director of the company for personal reasons.

Triton BioSystems has hired Dr. Donald S. Masters as its president and CEO.

Celgene has named Thomas Daniel to the new position of president of Celgene research.

Sciele Pharma announced the retirement of John N. Kapoor, Ph.D. from the company's board of directors. Dr. Kapoor was a founder of Sciele Pharma and has served as a director since December 1996.

PAREXEL International has created a new, strategic leadership position of CIO and has appointed Christopher Rieder to the role.

Watson Pharmaceuticals has named Thomas R. Giordano as senior vice president, CIO.

Bill Chen is resigning from his position as CFO of Wex Pharmaceuticals.

Micell Technologies has appointed David Dresner to serve as CFO on an interim basis. Dresner replaces the company's current CFO, Jon Kennedy, who is leaving Micell to assume financial management responsibilities with another Raleigh-based company.

Columbia Laboratories announced the appointment of James A. Meer to the position of senior vice president, CFO and treasurer, succeeding David L. Weinberg, who is leaving to pursue other opportunities.

Ilypsa has promoted Gerrit Klaerner, Ph.D., to senior vice president and chief business officer.

INC Research as named Ronald E. Keeney, M.D., as its vice president of pediatric product development.

Recordati has named Gianni Soro to the position of general manager pharmaceuticals Italy.

Elite Pharmaceuticals has begun a strategic alliance with Dr. Veerappan Subramanian under which Dr. Subramanian has joined Elite's board of directors and will serve as strategic advisor to Elite on the research, development and commercialization of Elite's existing pipeline.

Ambit has appointed Brian J. Druker, M.D., and Gordon B. Mills, M.D., Ph.D., as the first members of its clinical oncology advisory board.

Helicos BioSciences has added John Quackenbush, Ph.D. of Dana Farber Cancer Institute, and David Liu, Ph.D. of Harvard University, to its scientific advisory board.

Bionovo announced that Dr. Terry Speed will join the company's scientific advisory board.

NeoStem has appointed Stephen D. Nimer, MD, a prominent authority in hematologic oncology, to the company's scientific advisory board.

Advanced Life Sciences Holdings has named Theron E. Odlaug, Ph.D. to its board of directors.

Dr. Jeffrey M. Leiden, MD, PhD will join the board of Shire as a non executive director.

Norman C. Payson, M.D., former chairman and CFO of Oxford Health Plans, has been elected to Idenix's board of directors.

NGN Capital co-founder Georg Nebgen, Ph.D., was unanimously elected to the board of directors of Javelin Pharmaceuticals. Venture capitalist Peter Morgan Kash has stepped down from the board and will continue to serve with the company under contract.

Biophan Technologies has named Stan Yakatan to its board of directors.